Novel bioactive compounds from actinomycetes
- PMID: 7908142
- DOI: 10.1016/0923-2508(93)90071-9
Novel bioactive compounds from actinomycetes
Abstract
Actinomycetes form an enormous reservoir of secondary metabolites and enzymes. The potential for exploiting rare actinomycetes is highlighted by the discovery of novel compounds from strains of Spirillospora and Nocardioides. Novel compounds of well known classes of antibiotics, such as polyenes, continue to be discovered. For compounds containing a chromophore, the analysis by high-performance liquid chromatography coupled with a diode-array detector enables the elimination of producers of known compounds and facilitates the discovery of novel compounds or derivatives. The complexity of the regulatory mechanisms is illustrated by glutamine synthetase. The characterization of thermostable amylolytic, lignolytic, peroxidase and neuramidase activities, and the isolation of novel cellulolytic actinomycetes clearly demonstrate the potential of Actinomycetes as producers of enzymes.
Similar articles
-
Novel bioactive compounds from Actinomycetes: a short review (1988-1992).Res Microbiol. 1993 Oct;144(8):633-42. doi: 10.1016/0923-2508(93)90066-b. Res Microbiol. 1993. PMID: 8140282 Review.
-
Rare genera of actinomycetes as potential producers of new antibiotics.Antonie Van Leeuwenhoek. 2001 Sep;79(3-4):399-405. Antonie Van Leeuwenhoek. 2001. PMID: 11816986
-
Rare genera of actinomycetes as potential producers of new antibiotics.Antonie Van Leeuwenhoek. 2000 Dec;78(3-4):399-405. Antonie Van Leeuwenhoek. 2000. Corrected and republished in: Antonie Van Leeuwenhoek. 2001 Sep;79(3-4):399-405. PMID: 11386363 Corrected and republished. Review.
-
Marine actinomycetes as a source of novel secondary metabolites.Antonie Van Leeuwenhoek. 2005 Jan;87(1):37-42. doi: 10.1007/s10482-004-6538-8. Antonie Van Leeuwenhoek. 2005. PMID: 15726289
-
[New verticillate actinomycetes producing hexaene antibiotics].Mikrobiologiia. 1974 Jul-Aug;43(4):659-65. Mikrobiologiia. 1974. PMID: 4281456 Russian. No abstract available.
Cited by
-
Isolation and characterisation of acaricidal and larvicidal novel compound (2S,5R,6R)-2-hydroxy-3,5,6-trimethyloctan-4-one from Streptomyces sp. against blood-sucking parasites.Parasitol Res. 2012 Sep;111(3):1151-63. doi: 10.1007/s00436-011-2493-2. Epub 2011 Jun 23. Parasitol Res. 2012. PMID: 21698506
-
Bioactivities of secondary metabolites of two actinomycetes Streptomyces parvulus GloL3, and Streptomyces lienomycini SK5, endophytes of two Indian medicinal herbs- Globba marantina L. and Selaginella kraussiana (Kunze) A. Braun.Braz J Microbiol. 2025 Jun;56(2):779-795. doi: 10.1007/s42770-025-01615-y. Epub 2025 Jan 29. Braz J Microbiol. 2025. PMID: 39878823
-
Vector systems allowing efficient autonomous or integrative gene cloning in Micromonospora sp. strain 40027.Appl Environ Microbiol. 2003 Jun;69(6):3144-51. doi: 10.1128/AEM.69.6.3144-3151.2003. Appl Environ Microbiol. 2003. PMID: 12788709 Free PMC article.
-
Continuing hunt for endophytic actinomycetes as a source of novel biologically active metabolites.World J Microbiol Biotechnol. 2015 Dec;31(12):1863-75. doi: 10.1007/s11274-015-1950-y. Epub 2015 Sep 26. World J Microbiol Biotechnol. 2015. PMID: 26410426
-
Isolation and characterization of Micromonospora phage PhiHAU8 and development into a phasmid.Appl Environ Microbiol. 2004 Jul;70(7):3893-7. doi: 10.1128/AEM.70.7.3893-3897.2004. Appl Environ Microbiol. 2004. PMID: 15240260 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical